Product Code: GVR-2-68038-825-1
Fractional Flow Reserve Market Growth & Trends:
The global fractional flow reserve market size is expected to reach USD 1,668.8 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.3% from 2023 to 2030. The widening proliferation of cardiovascular diseases coupled with mounting cases of diabetes in developed as well as developing economies is escalating the growth of the market. Furthermore, the launch of novel devices in the fractional flow reserve (FFR) market such as guidewires and monitoring systems are also anticipated to aid market growth. For instance, in May 2019, Philips launched the IntraSight interventional applications platform. This platform offers a comprehensive unit of IVUS, FFR, IFR, and co-registration modalities to speed up routine procedures and simplify complex interventions.
In an independent study by SCAI in 2019, it was observed that FFR possesses the capability to decide the treatment plan for Acute Coronary Syndrome (ACS) which could be either PCI (Percutaneous Coronary Intervention) or CABG (Coronary Artery Bypass Grafting). This is anticipated to help the physicians and provide an effective treatment plan to patients, thereby increasing adoption of the same in the coming five years.
The COVID-19 pandemic is expected to have a positive impact on the market growth owing to growing initiatives by market players, government support, and others. For instance, in July 2020, Acist Medical Systems, Inc., a Bracco Group Corporation, proclaimed the international introduction of the Navvus II rapid exchange FFR microcatheter, a second-generation device for use with the firm's RXi rapid exchange FFR system in percutaneous coronary intervention procedures. Moreover, consolidation activities, such as the acquisition of St. Jude by Abbott in 2017 in order to increase its foothold in the cardiovascular devices market, are likely to keep the market highly competitive and thereby augur well for the overall market growth.
Fractional Flow Reserve Market Report Highlights:
- The FFR guidewires segment dominated the market with the largest revenue share of over 55% in 2022. This is attributed to their extensive usage in diagnostic cardiovascular procedures and coronary arteries.
- The FFR monitoring systems segment is expected to grow at the fastest CAGR of 9.5% over the forecast period.
- The single-vessel CAD segment dominated the market and held the largest revenue share of around 50% in 2022. This is attributed to the extensive use of the device in CAD cases, combined with the increasing number of elderly populations.
- The multi-vessel coronary artery disease CAD segment is expected to grow at the fastest CAGR of 9.5% over the forecast period, as this disease is a matured phase of single-vessel CAD.
- North America dominated the fractional flow reserve market and held the largest market share of around 40% in 2022. This is attributed to favorable government policies aimed at promoting the adoption of medical devices and the presence of a well-established healthcare infrastructure.
- Asia Pacific is expected to grow at the fastest CAGR of 9.8% over the forecast period due to increased diabetes and cardiovascular disease cases and rising disposable income.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Fractional Flow Reserve Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
- 3.4. Fractional Flow Reserve Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
Chapter 4. Fractional Flow Reserve Devices: Product Estimates & Trend Analysis
- 4.1. Fractional Flow Reserve Market: Key Takeaways
- 4.2. Fractional Flow Reserve Market: Movement & Market Share Analysis, 2022 & 2030
- 4.3. FFR Guidewires
- 4.3.1. FFR guidewires market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4. FFR Monitoring Systems
- 4.4.1. FFR monitoring systems market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Fractional Flow Reserve Devices: Application Estimates & Trend Analysis
- 5.1. Fractional Flow Reserve Market: Key Takeaways
- 5.2. Fractional Flow Reserve Market: Movement & Market Share Analysis, 2022 & 2030
- 5.3. Multi-vessel CAD
- 5.3.1. Multi-vessel CAD market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4. Single-vessel CAD
- 5.4.1. Single-vessel CAD market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Fractional Flow Reserve Market: Regional Estimates & Trend Analysis
- 6.1. Regional Outlook
- 6.2. Fractional Flow Reserve Market by Region: Key Takeaway
- 6.3. North America
- 6.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.2. U.S.
- 6.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.3. Canada
- 6.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4. Europe
- 6.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.2. UK
- 6.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.3. Germany
- 6.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.4. France
- 6.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.5. Italy
- 6.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.6. Spain
- 6.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.7. Sweden
- 6.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.8. Norway
- 6.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.9. Denmark
- 6.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5. Asia Pacific
- 6.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.2. Japan
- 6.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.3. China
- 6.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.4. India
- 6.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.5. Australia
- 6.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.6. Thailand
- 6.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.7. South Korea
- 6.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6. Latin America
- 6.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.2. Brazil
- 6.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.3. Mexico
- 6.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.4. Argentina
- 6.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7. MEA
- 6.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.2. Saudi Arabia
- 6.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.3. South Africa
- 6.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.4. UAE
- 6.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.5. Kuwait
- 6.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Market Participant Categorization
- 7.2.1. OpSens Medical
- 7.2.1.1. Company overview
- 7.2.1.2. Financial performance
- 7.2.1.3. Product benchmarking
- 7.2.1.4. Strategic initiatives
- 7.2.2. Abbott
- 7.2.2.1. Company overview
- 7.2.2.2. Financial performance
- 7.2.2.3. Product benchmarking
- 7.2.2.4. Strategic initiatives
- 7.2.3. Boston Scientific Corporation
- 7.2.3.1. Company overview
- 7.2.3.2. Financial performance
- 7.2.3.3. Product benchmarking
- 7.2.3.4. Strategic initiatives
- 7.2.4. ACIST Medical Systems
- 7.2.4.1. Company overview
- 7.2.4.2. Financial performance
- 7.2.4.3. Product benchmarking
- 7.2.4.4. Strategic initiatives
- 7.2.5. Koninklijke Philips N.V.
- 7.2.5.1. Company overview
- 7.2.5.2. Financial performance
- 7.2.5.3. Product benchmarking
- 7.2.5.4. Strategic initiatives
- 7.2.6. Opsens Inc.
- 7.2.6.1. Company overview
- 7.2.6.2. Financial performance
- 7.2.6.3. Product benchmarking
- 7.2.6.4. Strategic initiatives
- 7.2.7. HeartFlow, Inc.
- 7.2.7.1. Company overview
- 7.2.7.2. Financial performance
- 7.2.7.3. Product benchmarking
- 7.2.7.4. Strategic initiatives
- 7.2.8. Siemens Healthcare Gmbh
- 7.2.8.1. Company overview
- 7.2.8.2. Financial performance
- 7.2.8.3. Product benchmarking
- 7.2.8.4. Strategic initiatives
- 7.2.9. Pie Medical Imaging B.V.
- 7.2.9.1. Company overview
- 7.2.9.2. Financial performance
- 7.2.9.3. Product benchmarking
- 7.2.9.4. Strategic initiatives
- 7.2.10. CathWorks
- 7.2.10.1. Company overview
- 7.2.10.2. Financial performance
- 7.2.10.3. Product benchmarking
- 7.2.10.4. Strategic initiatives
- 7.2.11. Medis Medical Imaging Systems B.V.
- 7.2.11.1. Company overview
- 7.2.11.2. Financial performance
- 7.2.11.3. Product benchmarking
- 7.2.11.4. Strategic initiatives